Immunodeficiency secondary to biologics
Journal of Allergy and Clinical Immunology · 2023-03 · 151 (3) · 686-690
DOI: 10.1016/j.jaci.2023.01.012 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-03. Verfasst von Roxane Labrosse und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Biological Products, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada.
- Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada; Department of Microbiology, Immunology and Infectious Diseases, CHU Sainte-Justine, Uni…
Zitieren
APA
Labrosse, R., & Haddad, E. (2023). Immunodeficiency secondary to biologics. Journal of Allergy and Clinical Immunology, 151(3), 686-690. https://doi.org/10.1016/j.jaci.2023.01.012
Vancouver
Labrosse R, Haddad E. Immunodeficiency secondary to biologics. Journal of Allergy and Clinical Immunology. 2023;151(3):686-690. doi:10.1016/j.jaci.2023.01.012
BibTeX
@article{Labrosse2023,
author = {Labrosse, Roxane and Haddad, Elie},
title = {Immunodeficiency secondary to biologics},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
volume = {151},
number = {3},
pages = {686--690},
doi = {10.1016/j.jaci.2023.01.012}
}
EUVIMED